Take a look at our UFDI spotlights today at the American Diabetes Association 85th Scientific Sessions! #ADASciSessions

2. NIS2+ correlates well with MASH - a good non-invasive biomarker of disease activity or steatohepatitis due to MASLD UF Diabetes Institute UF Medicine

UF Diabetes Institute UF Medicine 3. In young adults with T2D, routine clinical variables can differentiate subtypes and predict disease outcome.

UF Diabetes Institute UF Medicine 4. Young adults have a high prevalence of cardiometabolic risk factors, less likely to receive treatment for risk factors, and less likely to achieve risk factor control when on treatment.

UF Diabetes Institute UF Medicine 5. MR-PDFF and HOMA-IR correlates with MASH severity - other potential non-invasive markers to identify high-risk patients!

UF Diabetes Institute UF Medicine 6. T2D with obesity has a 3-fold increase risk of at-risk MASH —> very high risk group who must undergo screening!

UF Diabetes Institute UF Medicine 7. Insulin resistance in T2D is associated with clinically significant fibrosis.

UF Diabetes Institute UF Medicine 8. In people with obesity but without T2D, once again insulin resistance as measured by HOMA-IR was associated with both hepatic steatosis and fibrosis.

UF Diabetes Institute UF Medicine 9. High frequency of OSA and insomnia in people with T1D with sleep disorders. OSA in T1D is associated with worse glycemic control and metabolic health.

UF Diabetes Institute UF Medicine 10. GMI correlates well with HbA1C but is highly influenced by 90 day CGM wear percentage - the more you wear your CGM, the better the GMI correlates with the HbA1c.

Dr. Todd Brusko, Director of the University of Florida Diabetes Institute, will be presenting the keynote address at FOCIS 2025. His talk, titled “Decoding Type 1 Diabetes: AI-Powered Discoveries from Peripheral Blood and Organ Donor Tissues,” will showcase cutting-edge

Please join us Monday, July 7th for a Seminar entitled "The Role of Hybrid Insulin Peptides in the Pathogenesis of Type 1 Diabetes" by Jason Groegler, a postdoctoral candidate for Russ Holger lab. Click here for the zoom link ufl.zoom.us/j/91379205086?… UF Health UF Medicine

Join Miguel A. Medina-Serpas today at 12:30pm for his dissertation defense, exploring transcriptional profiling in type 1 diabetes. To join via zoom, click here ufl.zoom.us/j/5193985570?p… UF Medicine Todd M. Brusko

A new grant from the American Diabetes Association's Innovative Translational Clinical Science program was awarded to Dr. Ashby Walker, Director of Community and Population Health for the UFDI. This grant will allow the highly successful ECHO Diabetes program to grow into a

A new article in The Journal of Clinical Endocrinology & Metabolism, led by Dr. Aaron W. Michels and co-authored by Dr. Todd Brusko, Dr. Carmella Evans-Molina, Dr. Dirk Homann, Dr. Sarah J. Richardson, and Dr. Alvin C. Powers, outlines key research priorities for advancing our

Mark your calendars for next Tuesday, July 22nd, for a seminar featuring Dr. Clayton Matthews presented by the(sugar)science. To learn more and to register, click this link or scan the QR code us02web.zoom.us/meeting/regist… UF Health UF Medicine

UFDI's Dr. Laura Jacobsen and Dr. Sarah Westen's article in Nature Reviews Endocrinology is out today! Their article emphasizes that the language used by healthcare professionals when discussing diabetes can significantly impact patients' emotional well-being, self-care, and health outcomes.

Don’t miss today’s the(sugar)science Th1nk Tank talk! Join us from 12–1 PM as Miguel Medina, PhD Candidate, shares his groundbreaking research on a lymphotoxin beta signature in type 1 diabetes. To register via zoom, click here us02web.zoom.us/j/89890271658

We had the pleasure of hosting Dr. Manuela Battaglia, Managing director at INNODIA in Belgium here at the UF Diabetes Institute. What an unforgettable day of exploration, partnership, and shared commitment to advancing type 1 diabetes research! Manuela Battaglia Mark A. Atkinson